Knowledge is power: Get the latest news

Get Involved

Since 1990, the International Myeloma Foundation

has been dedicated to improving the quality of life for myeloma patients

while working toward prevention and a cure

Multiple myeloma is a cancer of the bone marrow plasma cells, white blood cells that make antibodies. A cancerous or malignant plasma cell is called a myeloma cell. Myeloma is called “multiple” because there are frequently multiple patches or areas in bone where it grows. It can appear as both a tumor and/or an area of bone loss, and it affects...

Learn about the latest myeloma research. Get a front row seat at the most critical medical meetings. Watch Dr. Brian Durie, IMF Chairman, address issues that are important to the entire myeloma community. IMF TV brings it all to you.

The IMF’s guide through the myeloma journey, from diagnosis to long-term survival. Start by understanding the disease and diagnosis, and proceed through the steps to learn the best tests, treatments, and supportive care currently available.

There is a worldwide network of more than 150 myeloma-specific support groups that hold regular meetings. We encourage you to click the button below to locate a group in your area and connect with other myeloma survivors and caregivers. The IMF applauds the efforts and commitment of these groups, and conducts an annual Summit to offer help,...

The IMF’s InfoLine is there for you for your myeloma-related questions and concerns. The InfoLine team consistently provides callers with best information about myeloma in a caring and compassionate manner. The InfoLine is staffed by Paul Hewitt, Judy Webb, and Missy Klepetar.

Smart Patients is an online community where patients and caregivers affected by complex illness learn from each other about treatments, challenges, and how it all fits into the context of their experience. Collectively, our experience is a vast and often untapped resource. Together, we can become more expert in our conditions and receive better...

Introducing the IMF’s Black Swan Research Initiative® Understanding that the search for a cure for multiple myeloma demands constant innovation, the IMF has launched the Black Swan Research Initiative®, a unique project to develop the first definitive cure for myeloma. Led by a multinational consortium of leading myeloma experts, we are bridging...

The International Myeloma Working Group (IMWG) was formed by the IMF to encourage dialog and collaboration among the world’s leading myeloma experts. IMWG members are divided into workgroups. Researchers in each group work together to examine such important topics as frontline therapy, continuous therapy, the role of transplant, genetic risk...

In 2006, the IMF founded the Nurse Leadership Board® as a professional partnership to rep­resent nurse experts caring for myeloma patients at leading medical centers. The NLB is improving the nurs­ing care and self-care of patients with myeloma via consensus publi­cations, symposia, multimedia, and research.  

Advocacy is the act of supporting a cause or idea. It involves speaking out on issues that you care about and offering ways to improve upon them. Anyone can become an advocate! The IMF Advocacy group helps guide individuals to advocate for critical health issues that affect the myeloma community. Whether you are a myeloma patient, caregiver,...

​ Over the years, the IMF has been a resource for veterans seeking information about myeloma. Talking with vets has made us aware that many are in need of resources that can guide them through the process of applying for Veterans Administration (VA) benefits, including disability. The IMF’s new Veterans Against Myeloma (VAM) website addresses that...

The International Myeloma Foundation (IMF) advocates on behalf of patients affected by multiple myeloma. We advocate to insure an increase in accessibility to high-quality diagnostics and treatments, for funding of myeloma-related research, and to end insurance coverage disparities for treatment. The IMF works with the entire myeloma community in...